The California wildfires severely affected patients with cancer, requiring evacuation protocols, community support, and ...
Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...
Alan Tan, MD, discusses upcoming trials that could change the landscape of frontline and adjuvant renal cell carcinoma ...
The FDA has granted a 510 (k) clearance to the Ibex Prostate Detect software (formerly Galen Second Read). The Ibex Prostate ...
Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.
Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss which populations are seen as the most underrepresented in oncology clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results